Daniele M Rottkamp, MD

Offices

5 locations · Sutter Bay Medical Foundation · University of California San Francisco

Looking this up.

Hospitals listed: Mills-Peninsula Medical Center. That is not proof they admit you there this week.

Plans that list them

5 plans · 3 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Rottkamp’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

5 of 5 plans

Sort by

Plans whose provider directory lists this clinician

Alignment Health Sutter Advantage +More (HMO)	Alignment Health Plan	Listed	Oct 3, 2026
Imperial Courage Plan (HMO)	Imperial Health Plan of California, Inc.	Listed	Sep 1, 2026
Imperial Dynamic Plan (HMO)	Imperial Health Plan of California, Inc.	Listed	Sep 1, 2026
Imperial Senior Value (HMO C-SNP)	Imperial Health Plan of California, Inc.	Listed	Sep 1, 2026
DualConnect (HMO D-SNP)	Santa Clara Family Health Plan	Listed	Sep 1, 2026

California Medical Board record

Licence A111506 · Current

Licensed to practise in California · since 2010 · expires 2027-07-31 · University of Pennsylvania School of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend it
Overall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025

See every measure and the patient survey for Peninsula Medical Center

Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Sort by

Every scored measure at Peninsula Medical Center

Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections	0.139	Better	Oct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections	0.242	Better	Oct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths	1.21 (0.27 to 2.15) · 1,258 cases	No different	Jul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths	0.81 (0.51 to 1.1)	No different	Jul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths	155.44 (112.67 to 198.21) · 90 cases	No different	Jul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths	2.5 · 32 cases	None	Jul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths	7.1 · 82 cases	None	Jul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths	10 · 188 cases	None	Jul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths	9 · 473 cases	None	Jul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths	14.8 · 342 cases	None	Jul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths	9.4 · 485 cases	None	Jul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths	2.9 · 3,730 cases	None	Jul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths	0.2 (0 to 0.4) · 6,904 cases	No different	Jul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths	0.21 (0.02 to 0.4) · 7,052 cases	No different	Jul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths	3.41 (1.43 to 5.39) · 1,695 cases	No different	Jul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths	1.72 (0.17 to 3.28) · 665 cases	No different	Jul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths	2.11 (0.66 to 3.56) · 1,545 cases	No different	Jul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths	7.1 (1.3 to 12.9) · 670 cases	No different	Jul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths	5.96 (2.63 to 9.29) · 653 cases	No different	Jul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths	1.61 (0.15 to 3.08) · 418 cases	No different	Jul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths	0.14 (0 to 0.78) · 5,539 cases	No different	Jul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths	3.7 · 192 cases	None	Apr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections	0.215	No different	Oct 2024 – Sep 2025
MRSA BacteremiaInfections	0.263	No different	Oct 2024 – Sep 2025
SSI - Colon SurgeryInfections	0.74	No different	Oct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits	14.3 · 300 cases	None	Jul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits	19 · 702 cases	None	Jul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits	1.2 · 207 cases	None	Jul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits	-13.6 · 531 cases	None	Jul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits	24.3 · 343 cases	None	Jul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits	18.1 · 449 cases	None	Jul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits	4.5 (2.8 to 7) · 85 cases	No different	Jan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits	9.6 (6.7 to 13.7) · 85 cases	No different	Jan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits	5.7 · 189 cases	None	Jul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits	11 · 45 cases	None	Jul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits	20.6 · 117 cases	None	Jul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits	13 (9.7 to 17.2) · 584 cases	No different	Jan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits	0.9 (0.7 to 1.2) · 764 cases	No different	Jan 2024 – Dec 2024

What patients said (523 patients answered, 27% of those asked)

Sort by

Patient survey stars by topic at Peninsula Medical Center

Cleanliness	4
Nurse communication	4
Doctor communication	4
Communication about medicines	3
Discharge information	4
Overall hospital rating	4
Quietness	3
Recommend hospital	5

Sort by

Share of patients giving the best answer at Peninsula Medical Center

Room was "always" clean	76%
Nurses "always" communicated well	81%
Doctors "always" communicated well	80%
Staff "always" explained	58%
Yes, staff "did" give patients this information	89%
Yes, staff "did" give patients information about help after discharge	87%
Doctors "always" explained things so they could understand	74%
Doctors "always" listened carefully	79%
Doctors "always" treated them with courtesy and respect	87%
Patients who gave a rating of "9" or "10" (high)	75%
Staff "always" explained new medications	72%
Nurses "always" explained things so they could understand	77%
Nurses "always" listened carefully	79%
Nurses "always" treated them with courtesy and respect	88%
"Always" quiet at night	54%
"YES", patients would definitely recommend the hospital	78%
Staff "always" explained possible side effects	44%
Yes, staff "did" give patients information about possible symptoms	90%

Original Medicare doctor bills

$444,756

Medicare paid this office $444,756 for 373 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Sort by

Largest Original Medicare bills

Injection, romosozumab-aqqg, 1 mg	34	$300,925	None
Injection, denosumab, 1 mg	40	$81,829	None
Long return visit (40+ min)	91	$14,884	$153
Return visit (30+ min)	104	$12,633	$111
Short return visit (20+ min)	143	$12,456	$77

See all 10 services

Sort by

Every Original Medicare service billed

Injection, romosozumab-aqqg, 1 mg	34	$300,925	None
Injection, denosumab, 1 mg	40	$81,829	None
Long return visit (40+ min)	91	$14,884	$153
Return visit (30+ min)	104	$12,633	$111
Short return visit (20+ min)	143	$12,456	$77
Injection of drug or substance under skin or into muscle	70	$5,968	$14
New patient visit (45+ min)	27	$3,785	$140
Short return visit	53	$3,211	$53
New patient visit (30+ min)	23	$2,100	$91
New patient visit (60+ min)	11	$2,093	$190

Who their Medicare patients are

373 Original Medicare patients in 2024. Average age 76 · Women 75% · Also on Medicaid 5% · Health risk score 0.98. At or below the middle of the specialty; the typical endocrinology clinician is at 1.46.

Conditions among them: High blood pressure 56% · Diabetes 24% · Coronary heart disease 22% · Chronic kidney disease 18% · Atrial fibrillation 17% · Depression 17% · Cancer 16% · Heart failure 9% · COPD 5% · Dementia 5% · Stroke 4%.

The office billed $1,333,673, Medicare allowed $568,536 and paid $444,756; for 41,284 services of 18 kinds; $386,010 of it was for drugs given in the office and $58,746 for care.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Sort by

Original Medicare by year

2024	373	41,284	76	0.98	$1,333,673	$444,756
2023	336	46,143	75	0.88	$1,310,582	$445,621
2022	331	20,975	76	0.86	$698,121	$234,757
2021	306	5,407	76	0.89	$316,270	$107,744
2020	240	1,968	76	0.90	$167,481	$52,963
2019	202	1,222	74	0.96	$125,522	$38,213
2018	249	2,033	75	1.07	$210,010	$57,611
2017	267	3,094	73	1.02	$299,599	$79,037
2016	238	3,020	74	1.06	$268,912	$71,986
2015	131	805	74	1.19	$113,628	$30,505

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 10 services

Sort by

Original Medicare services billed in 2023

Injection, romosozumab-aqqg, 1 mg	38	$339,005	None
Injection, denosumab, 1 mg	27	$47,050	None
Return visit (30+ min)	132	$18,373	$111
Long return visit (40+ min)	69	$12,701	$159
Short return visit (20+ min)	114	$10,147	$76
Injection of drug or substance under skin or into muscle	66	$6,402	$14
New patient visit (60+ min)	23	$4,667	$203
New patient visit (45+ min)	19	$2,840	$149
Short return visit	23	$1,535	$50
Telephone medical discussion with physician, 11-20 minutes	11	$1,167	$73

2022: 9 services

Sort by

Original Medicare services billed in 2022

Injection, romosozumab-aqqg, 1 mg	14	$132,047	None
Injection, denosumab, 1 mg	26	$46,489	None
Return visit (30+ min)	161	$21,029	$113
Short return visit (20+ min)	93	$9,521	$83
Long return visit (40+ min)	48	$7,845	$157
New patient visit (45+ min)	46	$6,202	$135
New patient visit (60+ min)	29	$5,536	$191
Injection of drug or substance under skin or into muscle	39	$2,257	$14
Short return visit	11	$616	$47

2021: 7 services

Sort by

Original Medicare services billed in 2021

Injection, denosumab, 1 mg	22	$32,624	None
Return visit (30+ min)	121	$15,885	$113
Long return visit (40+ min)	51	$8,845	$167
New patient visit (60+ min)	41	$8,529	$208
New patient visit (45+ min)	58	$8,498	$147
Short return visit (20+ min)	73	$6,956	$80
Injection of drug or substance under skin or into muscle	26	$780	$14

2020: 9 services

Sort by

Original Medicare services billed in 2020

Injection, denosumab, 1 mg	16	$25,277	None
Return visit (30+ min)	76	$8,559	$91
Short return visit (20+ min)	68	$4,967	$62
New patient visit (45+ min)	36	$4,542	$126
New patient visit (30+ min)	36	$3,617	$100
Long return visit (40+ min)	12	$1,002	$84
Telephone medical discussion with physician, 11-20 minutes	14	$952	$68
Injection of drug or substance under skin or into muscle	19	$422	$14
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	11	$398	$33

2019: 6 services

Sort by

Original Medicare services billed in 2019

Injection, denosumab, 1 mg	15	$14,384	None
Return visit (30+ min)	74	$8,675	$100
Short return visit (20+ min)	84	$6,351	$69
New patient visit (45+ min)	29	$4,366	$151
Long return visit (40+ min)	15	$1,873	$125
Injection of drug or substance under skin or into muscle	15	$334	$17

2018: 6 services

Sort by

Original Medicare services billed in 2018

Injection, denosumab, 1 mg	22	$22,602	None
Return visit (30+ min)	101	$11,667	$95
Short return visit (20+ min)	107	$8,904	$60
New patient visit (45+ min)	57	$7,994	$140
Long return visit (40+ min)	13	$1,774	$136
Injection of drug or substance under skin or into muscle	22	$556	$21

2017: 8 services

Sort by

Original Medicare services billed in 2017

Injection, denosumab, 1 mg	29	$32,871	None
New patient visit (45+ min)	97	$13,564	$140
Return visit (30+ min)	112	$12,814	$92
Short return visit (20+ min)	90	$8,180	$65
Fine needle aspiration using imaging guidance	26	$4,591	$139
Long return visit (40+ min)	19	$2,574	$95
Ultrasonic guidance for needle placement	26	$1,591	$59
Injection of drug or substance under skin or into muscle	30	$1,136	$25

2016: 8 services

Sort by

Original Medicare services billed in 2016

Injection, denosumab, 1 mg	28	$31,824	None
New patient visit (45+ min)	83	$11,740	$141
Return visit (30+ min)	103	$11,723	$94
Long return visit (40+ min)	34	$4,475	$121
Short return visit (20+ min)	46	$3,728	$65
Fine needle aspiration using imaging guidance	18	$3,051	$139
Injection of drug or substance under skin or into muscle	27	$1,650	$25
Ultrasonic guidance for needle placement	18	$1,237	$56

2015: 6 services

Sort by

Original Medicare services billed in 2015

New patient visit (45+ min)	63	$9,880	$157
Return visit (30+ min)	38	$3,848	$96
Long return visit (40+ min)	19	$2,817	$141
Fine needle aspiration using imaging guidance	19	$2,751	$145
New patient visit (30+ min)	11	$1,160	$105
Ultrasonic guidance for needle placement	19	$1,092	$57

Drugs they prescribed that Part D paid

$1,022,026

Pharmacies billed $1,022,026 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 2,056) in 2024. At or below the middle of the specialty; the typical endocrinology clinician is at 0%.

958 generic and 1,005 brand-name prescriptions · $1,022,026 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Sort by

Largest Part D drug costs

Mounjaro	151	$195,789	$1,297
Trulicity	134	$189,706	$1,416
Tymlos	33	$117,207	$3,552
Jardiance	79	$106,467	$1,348
Teriparatide	46	$100,113	$2,176

See all 36 drugs

Sort by

Every Part D drug this clinician prescribed

Mounjaro	151	$195,789	$1,297
Trulicity	134	$189,706	$1,416
Tymlos	33	$117,207	$3,552
Jardiance	79	$106,467	$1,348
Teriparatide	46	$100,113	$2,176
Ozempic	45	$79,826	$1,774
Forteo	12	$48,766	$4,064
Tresiba Flextouch U-100	43	$18,480	$430
Synthroid	131	$14,427	$110
Humalog Kwikpen U-100	47	$10,296	$219
Fiasp Flextouch	16	$8,872	$555
Cinacalcet	19	$7,527	$396
Basaglar Kwikpen U-100	19	$6,501	$342
Nano 2nd Gen Pen Needle	48	$4,706	$98
Lantus Solostar	42	$4,693	$112
Novolog Flexpen	17	$3,572	$210
Raloxifene	50	$2,950	$59
Levoxyl	44	$2,296	$52
Levothyroxine	191	$2,011	$11
Repaglinide	51	$1,815	$36
Metformin Hcl Er	108	$1,781	$16
Ultra-Fine Mini Pen Needle	20	$1,581	$79
Hydrocortisone	33	$1,493	$45
Alendronate	138	$1,390	$10
Liothyronine	18	$1,013	$56
Losartan	47	$566	$12
Eplerenone	12	$532	$44
Atorvastatin	50	$519	$10
Glipizide Er	28	$496	$18
Metformin	33	$395	$12
Rosuvastatin	26	$325	$13
Methimazole	32	$251	$8
Glimepiride	15	$225	$15
Amlodipine Besylate	15	$179	$12
Hydrochlorothiazide	26	$75	$3
Lisinopril-Hydrochlorothiazide	13	$45	$3

Year by year

Sort by

Part D prescribing by year

2024	2,056	290	0% (0)	49%	$1,022,026
2023	1,833	283	0% (0)	49%	$1,310,487
2022	1,603	273	0% (0)	48%	$930,255
2021	1,482	241	0% (0)	46%	$687,593
2020	1,292	218	0% (0)	44%	$534,071
2019	1,179	194	0% (0)	43%	$372,647
2018	1,394	198	0% (0)	45%	$373,629
2017	1,290	174	0% (0)	46%	$319,080
2016	791	157	0% (0)	46%	$193,490
2015	139	54	0% (0)	37%	$23,692
2014	20	None	0% (0)	55%	$16,951
2013	28	None	0% (0)	68%	$24,548

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 34 drugs

Sort by

Part D drugs prescribed in 2023

Forteo	78	$356,217	$4,567
Trulicity	128	$195,407	$1,527
Ozempic	71	$118,421	$1,668
Jardiance	73	$107,734	$1,476
Mounjaro	64	$104,460	$1,632
Tymlos	30	$98,839	$3,295
Teriparatide	30	$92,646	$3,088
Humalog Kwikpen U-100	46	$48,613	$1,057
Lantus Solostar	44	$27,093	$616
Novolog Flexpen	25	$14,857	$594
Tresiba Flextouch U-100	26	$14,106	$543
Synthroid	101	$12,333	$122
Basaglar Kwikpen U-100	16	$5,772	$361
Cinacalcet	17	$4,886	$287
Raloxifene	41	$4,809	$117
Nano 2nd Gen Pen Needle	51	$4,105	$80
Icosapent Ethyl	11	$3,399	$309
Levothyroxine	159	$2,449	$15
Alendronate	154	$2,082	$14
Metformin Hcl Er	97	$2,061	$21
Levoxyl	35	$1,622	$46
Hydrocortisone	28	$1,552	$55
Repaglinide	36	$1,466	$41
Testosterone	12	$1,090	$91
Ultra-Fine Mini Pen Needle	16	$1,071	$67
Glipizide Er	32	$769	$24
Liothyronine	22	$672	$31
Metformin	36	$590	$16
Atorvastatin	40	$496	$12
Rosuvastatin	25	$444	$18
Losartan	35	$371	$11
Methimazole	20	$288	$14
Glimepiride	11	$174	$16
Hydrochlorothiazide	26	$164	$6

2022: 38 drugs

Sort by

Part D drugs prescribed in 2022

Forteo	41	$169,363	$4,131
Tymlos	54	$131,976	$2,444
Trulicity	73	$124,262	$1,702
Teriparatide	36	$95,536	$2,654
Jardiance	48	$85,547	$1,782
Ozempic	52	$75,585	$1,454
Humalog Kwikpen U-100	31	$44,144	$1,424
Lantus Solostar	37	$19,620	$530
Mounjaro	11	$18,378	$1,671
Novolog Flexpen	24	$16,201	$675
Humalog	13	$15,841	$1,219
Synthroid	107	$12,078	$113
Levemir Flextouch	11	$9,960	$905
Androderm	14	$9,223	$659
Tresiba Flextouch U-100	14	$7,521	$537
Raloxifene	53	$6,358	$120
Basaglar Kwikpen U-100	12	$4,195	$350
Nano 2nd Gen Pen Needle	39	$3,488	$89
Repaglinide	41	$2,549	$62
Levothyroxine	132	$2,382	$18
Ultra-Fine Mini Pen Needle	30	$2,370	$79
Liothyronine	21	$2,081	$99
Alendronate	143	$1,783	$12
Metformin Hcl Er	84	$1,680	$20
Levoxyl	41	$1,260	$31
Cinacalcet	16	$1,218	$76
Hydrocortisone	17	$435	$26
Metformin	41	$412	$10
Glipizide Er	18	$351	$20
Calcitriol	14	$335	$24
Atorvastatin	29	$316	$11
Losartan	31	$279	$9
Methimazole	15	$267	$18
Rosuvastatin	23	$230	$10
Glimepiride	14	$225	$16
Glipizide	11	$103	$9
Lisinopril	11	$96	$9
Hydrochlorothiazide	28	$89	$3

2021: 35 drugs

Sort by

Part D drugs prescribed in 2021

Trulicity	74	$117,483	$1,588
Forteo	30	$114,951	$3,832
Tymlos	46	$96,656	$2,101
Jardiance	37	$47,265	$1,277
Ozempic	26	$45,304	$1,742
Teriparatide	17	$40,575	$2,387
Lantus Solostar	51	$27,864	$546
Humalog	30	$22,309	$744
Novolog Flexpen	29	$20,045	$691
Humalog Kwikpen U-100	23	$19,116	$831
Lantus	13	$12,457	$958
Synthroid	123	$11,698	$95
Levemir Flextouch	12	$9,750	$812
Cinacalcet	19	$7,403	$390
Raloxifene	55	$7,063	$128
Repaglinide	41	$3,950	$96
Testosterone	15	$3,386	$226
Nano 2nd Gen Pen Needle	37	$3,087	$83
Levothyroxine	92	$2,168	$24
Metformin Hcl Er	76	$1,590	$21
Ultra-Fine Mini Pen Needle	23	$1,530	$67
Levoxyl	31	$1,396	$45
Alendronate	114	$1,349	$12
Liothyronine	16	$1,032	$64
Metformin	55	$479	$9
Hydrocortisone	17	$442	$26
Glimepiride	16	$406	$25
Glipizide Er	22	$387	$18
Atorvastatin	26	$382	$15
Losartan	25	$376	$15
Rosuvastatin	32	$307	$10
Lisinopril	12	$179	$15
Methimazole	16	$171	$11
Glipizide	17	$165	$10
Hydrochlorothiazide	18	$77	$4

2020: 32 drugs

Sort by

Part D drugs prescribed in 2020

Forteo	44	$160,470	$3,647
Trulicity	73	$95,440	$1,307
Lantus Solostar	63	$37,672	$598
Cinacalcet	19	$31,042	$1,634
Humalog	21	$16,893	$804
Novolog Flexpen	16	$15,112	$945
Humalog Kwikpen U-100	17	$11,747	$691
Raloxifene	60	$9,966	$166
Levemir Flextouch	13	$9,821	$755
Synthroid	113	$8,807	$78
Androderm	12	$7,914	$660
Ultra-Fine Nano Pen Needle	41	$3,774	$92
Testosterone	12	$2,727	$227
Levothyroxine	96	$2,519	$26
Repaglinide	30	$2,424	$81
Metformin Hcl Er	79	$2,038	$26
Levoxyl	31	$1,799	$58
Ultra-Fine Short Pen Needle	23	$1,590	$69
Ultra-Fine Mini Pen Needle	21	$1,320	$63
Liothyronine	17	$786	$46
Alendronate	71	$624	$9
Calcitriol	18	$596	$33
Glipizide Er	22	$592	$27
Atorvastatin	32	$470	$15
Metformin	47	$369	$8
Methimazole	30	$367	$12
Losartan	32	$337	$11
Glipizide	13	$165	$13
Lisinopril	12	$104	$9
Hydrochlorothiazide	12	$97	$8
Gabapentin	11	$85	$8
Glimepiride	12	$74	$6

2019: 32 drugs

Sort by

Part D drugs prescribed in 2019

Trulicity	66	$75,403	$1,142
Forteo	13	$63,800	$4,908
Lantus Solostar	66	$33,905	$514
Victoza 3-Pak	21	$23,559	$1,122
Sensipar	11	$20,963	$1,906
Novolog Flexpen	31	$17,556	$566
Humalog Kwikpen U-100	26	$17,052	$656
Levemir Flextouch	21	$14,309	$681
Lantus	11	$14,285	$1,299
Januvia	14	$9,735	$695
Humalog	13	$9,253	$712
Synthroid	119	$6,457	$54
Raloxifene	32	$4,271	$133
Ultra-Fine Nano Pen Needle	35	$2,935	$84
Levothyroxine	83	$2,252	$27
Metformin Hcl Er	79	$2,119	$27
Repaglinide	26	$1,650	$63
Ultra-Fine Short Pen Needle	15	$1,159	$77
Ultra-Fine Mini Pen Needle	19	$1,121	$59
Liothyronine	21	$911	$43
Calcitriol	14	$758	$54
Levoxyl	24	$595	$25
Metformin	51	$536	$11
Atorvastatin	29	$481	$17
Lisinopril	17	$457	$27
Losartan	45	$438	$10
Methimazole	43	$411	$10
Glipizide Er	16	$389	$24
Alendronate	39	$316	$8
Glipizide	14	$122	$9
Amlodipine Besylate	13	$109	$8
Hydrochlorothiazide	11	$92	$8

2018: 31 drugs

Sort by

Part D drugs prescribed in 2018

Trulicity	63	$67,896	$1,078
Lantus Solostar	105	$49,886	$475
Humalog Kwikpen U-100	51	$34,875	$684
Victoza 3-Pak	24	$21,449	$894
Lantus	21	$17,484	$833
Novolog Flexpen	30	$16,018	$534
Januvia	15	$13,357	$890
Humalog	16	$13,310	$832
Levemir Flextouch	18	$12,372	$687
Synthroid	153	$9,404	$61
Androgel	11	$9,195	$836
Ultra-Fine Nano Pen Needle	43	$3,238	$75
Repaglinide	39	$3,015	$77
Raloxifene	27	$2,866	$106
Levothyroxine	70	$1,927	$28
Metformin Hcl Er	77	$1,855	$24
Ultra-Fine Mini Pen Needle	23	$1,536	$67
Liothyronine	26	$1,019	$39
Levoxyl	32	$954	$30
Atorvastatin	39	$705	$18
Calcitriol	14	$651	$46
Metformin	64	$611	$10
Methimazole	40	$563	$14
Novofine 32	11	$549	$50
Lisinopril	22	$523	$24
Glipizide Er	19	$495	$26
Rosuvastatin	12	$489	$41
Alendronate	50	$448	$9
Losartan	46	$427	$9
Glipizide	16	$159	$10
Hydrochlorothiazide	17	$142	$8

2017: 36 drugs

Sort by

Part D drugs prescribed in 2017

Lantus Solostar	100	$43,920	$439
Sensipar	15	$39,144	$2,610
Trulicity	31	$34,829	$1,124
Humalog Kwikpen U-100	43	$24,766	$576
Novolog Flexpen	33	$17,212	$522
Humalog	28	$16,071	$574
Januvia	17	$15,376	$904
Lantus	18	$13,895	$772
Victoza 3-Pak	16	$12,856	$803
Tradjenta	13	$10,230	$787
Levemir Flextouch	13	$8,352	$642
Levemir	22	$6,462	$294
Synthroid	103	$5,883	$57
Ultra-Fine Nano Pen Needle	58	$3,736	$64
Creon	15	$3,704	$247
Raloxifene	12	$2,507	$209
Levothyroxine	64	$1,996	$31
Ultra-Fine Mini Pen Needle	25	$1,491	$60
Ultra-Fine Short Pen Needle	12	$839	$70
Liothyronine	26	$741	$28
Repaglinide	15	$740	$49
Levoxyl	33	$712	$22
Metformin Hcl Er	51	$672	$13
Calcitriol	23	$637	$28
Atorvastatin	34	$593	$17
Metformin	49	$530	$11
Methimazole	40	$527	$13
Novofine 32	11	$526	$48
Alendronate	34	$356	$10
Propranolol	11	$303	$28
Losartan	32	$271	$8
Hydrochlorothiazide	24	$213	$9
Lisinopril	14	$166	$12
Glipizide	18	$104	$6
Glimepiride	11	$97	$9
Gabapentin	13	$89	$7

2016: 22 drugs

Sort by

Part D drugs prescribed in 2016

Lantus Solostar	74	$36,011	$487
Humalog	30	$12,807	$427
Novolog Flexpen	23	$12,035	$523
Levemir Flextouch	14	$11,945	$853
Levemir	12	$11,208	$934
Lantus	15	$9,951	$663
Humalog Kwikpen U-100	11	$6,548	$595
Bd Ultra-Fine Pen Needle	60	$3,351	$56
Synthroid	49	$2,463	$50
Levothyroxine	73	$1,642	$22
Metformin	51	$551	$11
Levoxyl	15	$447	$30
Liothyronine	12	$437	$36
Methimazole	17	$429	$25
Pravastatin	11	$398	$36
Calcitriol	13	$358	$28
Atorvastatin	21	$328	$16
Losartan	16	$208	$13
Alendronate	21	$176	$8
Glipizide	20	$97	$5
Hydrochlorothiazide	12	$95	$8
Amlodipine Besylate	14	$57	$4

2015: 4 drugs

Sort by

Part D drugs prescribed in 2015

Bd Ultra-Fine Pen Needle	11	$549	$50
Levothyroxine	14	$350	$25
Methimazole	12	$197	$16
Metformin	14	$104	$7

2014: 1 drug

Sort by

Part D drugs prescribed in 2014

Forteo	11	$16,440	$1,495

2013: 1 drug

Sort by

Part D drugs prescribed in 2013

Forteo	18	$24,320	$1,351

Money from drug and device companies

$23 in 2022

A payment is not proof that care is biased.

Sort by

Payments by company

Lilly USA	Mounjaro	$23	1 payment Meals for Mounjaro · 2022-07-13 · $23

See the published payment

Sort by

Every published payment

Lilly USA	Meals · 2022-07-13	Mounjaro	$23

Professional record

NPI: 1740492925
Licence: CA A111506, VA 0101244775, VA 0116018493California A111506: Current · expires 2027-07-31
Trained: Perelman School of Med at the University of Pennsylvania, 2006
Group: Sutter Bay Medical Foundation · University of California San Francisco
Video visits: Lists video visits
Gender: Female

More record details

Sole proprietor: No
Taxonomy: Federal specialty code 207RE0101X (207RE0101X); Federal specialty code 207RG0300X (207RG0300X); Student in a training program (390200000X)
Mailing address: 325 Distel Cir, Los Altos, CA, 94022
NPI first listed: 2007-05-03
NPI last updated: 2020-05-29
NPI record certified: 2020-05-29

This is when the NPI record was last certified, not a medical board exam.